ask="3.10"
ask_size="200"
average_daily_volume="100627"
bid="2.50"
bid_size="1000"
book_value="2.84"
change="-0.05"
change_from_200_day_moving_average="-0.87"
change_from_50_day_moving_average="0.44"
change_from_52_week_high="-3.44"
change_From_52_week_low="0.95"
change_in_percent="-1.67%"
close="2.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.04"
ebitda="-37.85M"
eps_estimate_current_year="-1.83"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="5860000"
high="3.05"
high_52_weeks="6.39"
last_trade_date="2/28/2017"
last_trade_price="2.95"
last_trade_size="1649"
last_trade_time="4:00pm"
low="2.95"
low_52_weeks="2.00"
market_capitalization="62.55M"
moving_average_200_day="3.82"
moving_average_50_day="2.51"
name="Strongbridge Biopharma plc"
notes="N/A"
one_year_target_price="14.33"
open="3.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-22.68%"
percent_change_from_50_day_moving_average="+17.56%"
percent_change_from_52_week_high="-53.83%"
percent_change_from_52_week_low="+47.50%"
previous_close="3.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.05"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="0.76"
stock_exchange="NMS"
symbol="SBBP"
volume="43264"
weeks_range_52="2.00 - 6.39"
